India MCA Corporate Compliance Enforcement — May 20, 2026

20-05-2026

DCM Shriram Fine Chemicals Ltd reported a net loss of ₹408 Lakh for Q4 FY26, compared to a profit of ₹427 Lakh in Q4 FY25, while full-year net profit fell sharply to ₹429 Lakh from ₹1,845 Lakh in FY25. Total income from operations declined 17.8% YoY in Q4 and 10.3% for the full year. The results reflect the impact of a composite scheme of arrangement that became effective in December 2025, which included the transfer of net assets and the issuance of new equity shares.

• · The Board recommended a final dividend of ₹0.40 per equity share (face value ₹2 each) for FY26, subject to shareholder approval.
• · The Company reversed an excess impairment loss of ₹223 Lakh on leasehold land in Dahej, Gujarat, and also reversed input tax credit of ₹229.02 Lakh due to withdrawal of a GST refund application.
• · The Company assessed the new Labour Codes and concluded there is no material financial impact based on existing remuneration structure.
• · The Scheme of Arrangement resulted in Daurala Foods and Beverages Private Limited becoming a wholly owned subsidiary of the Company.
• · The Company's business is a single primary segment: manufacturing of Organics and fine chemicals in India.

20-05-2026

Fine Organic Industries reported Q4 FY26 revenue of ₹625.3 Cr (+3.1% YoY, +12.7% QoQ) and PAT of ₹117.5 Cr (+21.0% YoY, +58.9% QoQ). For FY26, revenue grew 4.3% YoY to ₹2,365.8 Cr, but EBITDA declined 5.8% to ₹483.0 Cr and PAT rose only 1.6% to ₹417.1 Cr (including a ₹6.98 Cr insurance claim). The company announced a proposed acquisition of 80% of Oleofine Organics Sdn. Bhd., Malaysia for up to RM 34.210 million (~₹83 Cr), and incorporated subsidiaries in the US, UAE, and Thailand.

• · Exports accounted for ~55% of total revenue in Q4 FY26 and FY26; domestic demand 45%.
• · Raw material prices increased in FY26 vs FY25 and slightly in Q4FY26 vs Q3FY26.
• · Freight costs stabilized during the year but increased in Q4FY26 due to West Asia crisis.
• · The company made an incremental gratuity provision of ₹7.11 Cr for the quarter and nine months ended Dec 31, 2025 due to new Labour Code.
• · The proposed acquisition of Oleofine Organics Sdn. Bhd. is for up to 80% shares, aggregating up to RM 34.210 million (~₹83 Cr).
• · Equity investment in Fine Organics Americas LLC: USD 1.12 million (~₹9.6 Cr) for 160 acres in South Carolina.
• · Preference shares issued to WOS Fine Organic Industries (SEZ) Pvt. Ltd.: ₹65 Cr.
• · Equity infused in JV in Thailand: THB 22.50 million (~₹6.17 Cr).
• · Equity infused in Fine Organics FZE, Dubai: AED 200,000 (~₹49.48 L).
• · FY26 PAT includes a ₹6.98 Cr insurance claim for business interruption.

20-05-2026

NGL Fine-Chem Limited has informed the stock exchanges that its Board of Directors, scheduled to meet on May 21, 2026, will consider and recommend a final dividend for FY2025-26, in addition to approving audited financial results and fixing AGM-related dates. The trading window remains closed until May 23, 2026, per insider trading regulations.

• · Board meeting scheduled for May 21, 2026, to consider audited consolidated and standalone financial results for Q4 and FY ended March 31, 2026.
• · Board will also fix the date of the Annual General Meeting (AGM), book closure, and record date for AGM and e-voting.
• · Trading window closed from April 1, 2026, and will remain closed until 48 hours after the results declaration (May 23, 2026).

20-05-2026

Finelistings Technologies Limited has informed BSE that a Board Meeting will be held on May 28, 2026, to consider and approve the audited financial results for the half year and year ended March 31, 2026. The meeting will take place at the company's registered office in New Delhi. No financial figures or performance comparisons are provided in this filing.

• · Board Meeting scheduled for Thursday, 28th May 2026 at 4:00 PM IST.
• · Meeting location: Office 507, 5th Floor, Eros Corporate Tower, Nehru Place, South Delhi, New Delhi, India, 110019.
• · Agenda includes approval of Audited Financial Results for Half Year and Year ended 31st March 2026 along with Auditor's Report.
• · Company CIN: L74999DL2018PLC331504; Security ID: FTL / Code: 544173.

20-05-2026

Gandhar Oil Refinery (India) Limited has informed the stock exchanges that its Board of Directors will meet on May 26, 2026, to consider and approve the audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2026. The trading window for designated persons and their relatives remains closed until 48 hours after the outcome of the meeting.

• · Board meeting scheduled for May 26, 2026.
• · Agenda includes approval of audited financial results for Q4 and FY ended March 31, 2026.
• · Trading window closed from April 1, 2026, and will remain closed until 48 hours after the board meeting outcome.
• · Notice of the meeting is uploaded on the company's website at https://gandharoil.com/investor-relations/intimations-outcome-of-board-meeting.

20-05-2026

Camlin Fine Sciences Limited has informed the stock exchanges that its Board of Directors will meet on May 26, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The trading window for dealing in the company's equity shares remains closed from April 1, 2026, until 48 hours after the financial results are made public.

• · Board meeting scheduled for Tuesday, May 26, 2026
• · Agenda includes approval of audited standalone and consolidated financial results for Q4 FY26 and full year FY26
• · Trading window has been closed since April 1, 2026, and will reopen 48 hours after the results are made public
• · Filing made under Regulation 29 of SEBI (LODR) Regulations, 2015

20-05-2026

Gennex Laboratories Ltd has submitted newspaper publications to stock exchanges regarding a Board Meeting scheduled for May 30, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The notices were published in Business Standard (English) and Saksham (Telugu local) on May 20, 2026. No financial results or performance data are included in this filing.

• · Board meeting scheduled for Saturday, May 30, 2026 at the corporate office in Hyderabad.
• · Meeting agenda includes adoption of audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, along with statutory auditors' reports.
• · Newspaper notices published in Business Standard (English) and Saksham (Telugu local) on May 20, 2026.
• · The notice is also available on the company's website and BSE website.